Chemistry
- Our experts apply the resources to refine and purify the compound.
  Learn more
  Chemistry services
- Organometallic and heterocyclic chemistry
- Process development
- High-throughput synthesis
- PROTACs
- Photo- and electro-chemistry
- Flow chemistry
- DNA-encoded libraries synthesis
Biophysics
- See more clearly with our comprehensive biophysics platform.
  Learn more
  Biophysics services
- Protein production
- Cryo-electron microscopy
- X-ray crystallography
- Nuclear magnetic resonance (NMR)
- Surface plasmon resonance (SPR)
- Mass spectrometry (MS)
Pharmacology and DMPK
- Our custom solutions connect preclinical efficacy with clinical success.
  Learn more
  Pharmacology and DMPK services
- Biochemical assays
- Cellular and primary tissue assays
- ADME-PK and preformulation
- In vivo pharmacology
- Histology
- Biobank
- PK/PD
- Biomarkers
Drug Discovery
- Senior scientists with big pharma experience to support discovery projects.
  Learn more
  Drug Discovery services
- Chemistry
- Biophysics
- Pharmacology and DMPK
- Medicinal chemistry
- ADME-PK and preformulation
- Cheminformatics
- DNA-encoded libraries
Cosmetics
News
Events
Careers
About
Contact

News

All news Corporate news HR News New services & innovation Publications

Promoting Gender Equality in the workplace

Celebrating women and girls in science 2025

Evaluating the Diversity and Target Addressability of DELs using Scaffold Analysis and Machine Learning

The Discovery and Preclinical Profile of ALG-000184, a Prodrug of the Potent Hepatitis B Virus Capsid Assembly Modulator ALG-001075

Discovery of UCB9386: A Potent, Selective, and Brain-Penetrant Nuak1 Inhibitor Suitable for In Vivo Pharmacological Studies

October 2024: Breast Cancer Awareness Month

Novalix’s commitment to disability awareness

Nanoclick as potential tool to assess receptor mediated internalization

NovAliX and Bruker forge global alliance to transform drug discovery capabilities and elevate CRO service excellence

Determining the Affinity and Kinetics of Small Molecule Inhibitors of Galectin-1 Using Surface Plasmon Resonance